These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37043883)

  • 1. Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis.
    Dong F; Qu L; Duan Z; He Y; Ma X; Fan D
    Bioorg Chem; 2023 Jun; 135():106537. PubMed ID: 37043883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
    Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
    Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin.
    Kongtawelert P; Wudtiwai B; Shwe TH; Pothacharoen P; Phitak T
    Int Immunopharmacol; 2020 Sep; 86():106759. PubMed ID: 32663768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer.
    Deng X; Zhao J; Qu L; Duan Z; Fu R; Zhu C; Fan D
    Biochem Pharmacol; 2020 Aug; 178():114038. PubMed ID: 32422139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo.
    Duan Z; Wei B; Deng J; Mi Y; Dong Y; Zhu C; Fu R; Qu L; Fan D
    Biochem Biophys Res Commun; 2018 May; 499(3):482-487. PubMed ID: 29596831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK-STAT Pathway Inhibition Partially Restores Intestinal Homeostasis in
    Gonneaud A; Turgeon N; Boisvert FM; Boudreau F; Asselin C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33498747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8
    Fang W; Zhou T; Shi H; Yao M; Zhang D; Qian H; Zeng Q; Wang Y; Jin F; Chai C; Chen T
    J Exp Clin Cancer Res; 2021 Jan; 40(1):4. PubMed ID: 33390170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPIB Knockdown Inhibits the Immune Escape of Ovarian Cancer Cells by Reducing PD-L1 (CD274) Expression and Inactivating the JAK/STAT Pathway.
    Gu W; Qi G; Chen L
    Iran J Immunol; 2023 Sep; 20(3):335-347. PubMed ID: 37452634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
    Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
    Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy.
    Chen M; Wang S
    Int Immunopharmacol; 2024 Mar; 130():111717. PubMed ID: 38387193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL4I1 enhances PD-L1 expression through JAK/STAT signaling pathway in lung adenocarcinoma.
    Zhu J; Li Y; Lv X
    Immunogenetics; 2023 Feb; 75(1):17-25. PubMed ID: 36056935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rh4 inhibits the malignant progression of multiple myeloma and induces ferroptosis by regulating SIRT2.
    Ying Q; Lou J; Zheng D
    Clin Exp Pharmacol Physiol; 2023 Sep; 50(9):757-765. PubMed ID: 37452691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer cells promote CD169
    Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
    Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.
    Mimura K; Teh JL; Okayama H; Shiraishi K; Kua LF; Koh V; Smoot DT; Ashktorab H; Oike T; Suzuki Y; Fazreen Z; Asuncion BR; Shabbir A; Yong WP; So J; Soong R; Kono K
    Cancer Sci; 2018 Jan; 109(1):43-53. PubMed ID: 29034543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of the Tumor-Infiltrating CD8
    Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B
    Front Immunol; 2021; 12():734956. PubMed ID: 34603316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
    Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
    Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.